Albendazole 400mg

DRUG4 trials

Sponsors

University Ghent, Jennifer Keiser, Programme National de Lutte contre l'Onchocercose, Republic of the Congo

Conditions

HelminthiasisHookworm InfectionsInfection by Trichuris TrichiuraIntestinal WormsLoiasisLoiasis With Positive Blood Microfilaremia

Phase 2

Efficacy and Safety of Emodepside in Adolescents and Adults Infected With Hookworm

CompletedNCT05538767

Jennifer KeiserHookworm Infections

Start: 2022-09-16End: 2023-04-11Updated: 2023-06-15

Phase 3

21-day Double-blind Trial of Albendazole in Adults With Loa Loa Microfilaremia

Not yet recruitingNCT06613997

Programme National de Lutte contre l'Onchocercose, Republic of the CongoLoiasis, Loiasis With Positive Blood Microfilaremia

Start: 2025-01-15End: 2027-12-31Target: 100Updated: 2024-09-26

Phase 4

The Efficacy of Five Anthelmintic Regimes Against Trichuris Trichiura Infections in Schoolchildren in Jimma, Ethiopia

CompletedNCT01327469

University GhentInfection by Trichuris Trichiura

Start: 2010-12-31End: 2011-03-31Updated: 2011-04-01

Unknown Phase

Co-administration of IVM and ALB in School-based Deworming in Uganda

CompletedNCT06497075

Jennifer KeiserHelminthiasis, Intestinal Worms

Start: 2024-07-01End: 2024-10-19Updated: 2024-12-20

Related Papers

Efficacy and safety of emodepside compared with albendazole in adolescents and adults with hookworm infection in Pemba Island, Tanzania: a double-blind, superiority, phase 2b, randomised controlled trial.

2024-08-015 citations